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INTRODUCTION
Pancreaticobiliary diseases, including
acute and chronic pancreatitis and pancre-
atic cancer, are common, although there is
currently no training curriculum for
this subspecialty within medical gastro-
enterology. There is a need for medical
gastroenterologists experienced in the
management of these complex patients,
which increasingly involves a multidiscip-
linary approach. For both acute and
chronic pancreatitis, an aetiology should
be sought and surveillance conducted for
the development of complications, such as
exocrine and endocrine failure, nutri-
tional deficiencies and osteoporosis.
Furthermore, some patients may require
long-term support with smoking and
alcohol cessation. Pancreatic cancer and
cholangiocarcinoma have a poor progno-
sis that has not improved in recent years.
Although physicians are involved in the
initial diagnostic process, there are now
evolving areas where they can contribute
to the subsequent management. An
increasing workload is the assessment and
treatment of patients with cystic pancre-
atic lesions, detected incidentally on cross-
sectional imaging. Additionally, the man-
agement of biliary disorders, such as
complex strictures and Sphincter of Oddi
dysfunction, is equally challenging and
requires close working between hepatico-
pancreaticobiliary (HPB) physicians, radi-
ologists, surgeons and hepatologists.
A career in pancreaticobiliary medicine
may appeal to doctors in training. There
are rapidly developing diagnostic and
therapeutic procedures for patients with
pancreatic disease, emerging new clinical
problems in the acute and long-term set-
tings, together with a need for a persona-
lised management approach. More
physicians with such an interest will be
required as the incidence of many pan-
creaticobiliary disorders is expected to
rise as their aetiology is related to obesity
and higher alcohol consumption. This
paper discusses the potential develop-
ment and components of a training pro-
gramme in medical pancreatology, and
the authors would welcome feedback on
its suggestions.
CURRICULUM CONSIDERATIONS
The Joint Royal Colleges of Physicians
Training Board (JRCPTB) Gastroenterology
and Hepatology curriculum 2010 defines
the process of training and the required
competencies for the award of a certificate
of specialty training in gastroenterology.1
This curriculum documents the further
competencies required to achieve accredit-
ation in the subspecialties of hepatology,
inflammatory bowel disease and advanced
nutrition. There is also the subspecialty of
advanced endoscopy, which is specific to
the technical aspects of endoscopic retro-
grade cholangiographic pancreatography
(ERCP) and endoscopic ultrasound (EUS),
but not to the management of patients
with complex pancreatic and biliary disor-
ders. The curriculum does define basic
competencies in pancreaticobiliary medicine
(gallbladder, acute pancreatitis, chronic pan-
creatitis and pancreatic tumours) required
for all trainees, but there are many specific
and detailed areas that are omitted. A UK
specialised training in pancreaticobiliary
disease could be enhanced by the means of
a subspecialty curriculum for advanced
training in this area, rather than just the
technical aspects of specific endoscopic pro-
cedures (ERCP and EUS).
COMPONENTS OF A CURRICULUM
A curriculum in pancreaticobiliary medi-
cine should include three basic
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components: (i) clinical outpatient diagnosis and man-
agement of pancreaticobiliary diseases; (ii) diagnostic
and therapeutic radiological and endoscopic proce-
dures and (iii) delivery of multidisciplinary meetings
for both benign and malignant disorders. These three
areas are now discussed.
i. In the outpatient clinic, the pancreaticobiliary physician
provides a specialist service for the diagnosis and man-
agement of the relevant conditions, a service that cur-
rently does not exist in many hospitals. There is an
emerging range of such disorders requiring specialist
consideration and competencies, including
▸ investigation of the aetiology of acute and chronic
pancreatitis
▸ long-term management of chronic
pancreatitis
▸ assessment of patients with incidentally detected
pancreatic cysts
▸ diagnosis and coordination of care of pancreatic
cancer and cholangiocarcinoma
▸ management of emerging fields such as IgG4-related
disease
▸ diagnosis of patients with biliary strictures
▸ assessment of patients with functional biliary disorders
and indications for further investigation and treatment
(Sphincter of Oddi dysfunction).
In both acute and chronic pancreatitis, techniques
for investigating the underlying cause are advancing
with the development of, for example, EUS for detect-
ing microlithiasis. Patients with chronic pancreatitis
benefit from long-term follow-up by ensuring an
adequate nutritional status is maintained with appro-
priate pancreatic enzyme replacement and dietary sup-
plements; monitoring for the development of
diabetes, pancreatic cancer and osteoporosis; and
effective pain control and psychological support for
those with alcohol and smoking-related disease and
who require cessation support. Patients with pancre-
atic cancer are often diagnosed by medical gastroen-
terologists, but their care is continued by oncologists,
surgeons or palliative care physicians. Physicians can
provide an important role by assessing the need for
endoscopic stenting, pain control, nutritional require-
ments, monitoring for diabetes and depression, pro-
viding information and coordinating support and
assessing whether there is a family history of this
cancer to determine suitability for surveillance of
relatives.
An evolving role for the pancreaticobiliary physician
is in the management of patients with incidentally
detected pancreatic cysts, some of which are premalig-
nant (intraductal papillary mucinous neoplasms and
mucinous cystic neoplasms). Incidental pancreatic
cysts are reported in approximately 2% of abdominal
CT scans requested for the investigation of abdominal
or pelvic pain (not related to the cyst), or in the sur-
veillance of patients following treatment of other
cancers.2 The characterisation and management of
such cysts involves an awareness of the diagnostic
modalities, as well as an assessment of the risks and
benefits of surgical intervention, based on the degree
of potential risk of malignant transformation of the
cyst, and the consideration of any comorbidities and
treatment wishes. Specialist medical pancreatology
training is required to deliver effective care in this
evolving area.
ii A second role for the pancreaticobiliary physician is to
provide the emerging range of radiological, endoscopic
diagnostic and therapeutic services. These competencies
are already described as part of the module in advanced
endoscopy; however, we would argue that they would be
more relevant and could be expanded in a new pancreati-
cobiliary medicine curriculum. The competencies include
EUS and diagnostic fine needle aspiration (FNA), EUS
coeliac plexus neurolysis (EUS-CPN) and ERCP.
Previously obtaining cytological or histological diagnosis
of pancreatic cancer was difficult due to the relative
inaccessibility of the pancreas via ultrasound or
CT-guided approaches. This has been transformed with
the established use of linear EUS and FNA/biopsy for
sampling of both solid and cystic pancreatic lesions.3
EUS-CPN can deliver effective analgesia, via injection, of
neurolytic agents into the coeliac plexus.4 For patients
with chronic pancreatitis, ERCP can allow removal of
pancreatic ductal stones (with or without extracorporeal
shock wave lithotripsy) and treatment of duct strictures
in selected patients in whom surgery may be inappropri-
ate.5 Minimally invasive EUS-guided techniques are
developing and may in time become the standard of care
for the management of peripancreatic fluid collections.6
Ideally, the junior physician would become competent in
the basic therapeutic skills of interventional ERCP and of
diagnostic EUS, which would then develop on their
appointment to a consultant position. Trainees with a
particular aptitude for interventional procedures may be
taught others including cholangioscopy, intraductal ultra-
sound, complex pancreatic endotherapy (including extra-
corporal shock wave lithotripsy) and therapeutic EUS.
iii Training for pancreaticobiliary physicians should include
active participation in multidisciplinary team (MDT)
meetings for both benign and malignant pancreaticobili-
ary disease. Tertiary HPB cancer centres have forums for
discussing patients with cancer, but few have equivalent
pathways for patients with chronic pancreatitis, who have
equally difficult clinical problems. Chairing an MDT
involves an overview of the diagnostic procedures and
management of pancreatic conditions, as well as organisa-
tional skills in assembling the necessary professionals and
auditing the clinical outcomes. With the dismal prognosis
of pancreaticobiliary cancers, physicians could also
coordinate recruitment of patients into clinical trials, and
knowledge of such local, national and international
studies is imperative.
The training of junior physicians with an interest in
pancreaticobiliary medicine should occur in units that
provide a complete and comprehensive range of
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services for patients with pancreaticobiliary disorders.
These services as described above are outpatient
clinics, endoscopic and radiological procedures and
active involvement in MDT meetings with physicians
who work closely with HPB surgical units, specialist
oncologists and histopathologists. Although at present
such a range of services are available in only a few
departments in the UK, an aim of the new curriculum
would be to train gastroenterologists who would start
developing such facilities elsewhere. The increase in
the number of fully trained consultants would inevit-
ably make training more widely available in the
future. A relevant template for such a development
could be based on the recent British Society of
Gastroenterology (BSG) publication on the provision
of ERCP services that documents several criteria
including quality measures, minimum number of pro-
cedures performed and mentorship for new consul-
tants.7 The number of hospitals required to deliver
such a training curriculum in pancreaticobiliary medi-
cine is currently unknown. However, with the
expected rise in the requirement for HPB services,
and the increasing range of interventional services,
this requirement should be formally assessed if
national organisations for training in gastroenterology
accept the need for this new curriculum.
FUTURE DEVELOPMENTS
This paper has suggested reasons for justifying the
development of an advanced training subspecialty cur-
riculum in pancreaticobiliary medicine. The authors
would welcome comments on our proposal from all
health professionals involved in this area, including
specialty registrars, as to whether this would be an
attractive and rewarding career pathway. This training
should perhaps be a mandated part of that of any
gastroenterologist looking to develop a career in
ERCP and pancreaticobiliary EUS. If there is a consen-
sus for this proposal, we would work with the
JRCPTB Specialist Advisory Committee and the BSG
with the ultimate aim of improving the care and
quality of life for patients with these aggressive and
debilitating conditions.
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